Neuronetics Receives FDA 510(k) Premarket Notification Clearance For The Neurostar TMS Therapy System For Mental Health
accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K220127
Neuronetics Announces TMS Coverage Policies To Expand Patient Access To NeuroStar TMS Therapy For Mental Health
Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need it with the best neurohealth therapies in